Christian S Schade Aprea Therapeutics, Inc. (APRE) insider trading activity

Christian S Schade is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 259,246 shares of APRE, which is worth approximately $790,700. The most recent transaction as insider was on Jul 28, 2022, when has been sold 32,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 259K

0% 3M change

0% 12M change

Total Value Held $790,700

CHRISTIAN S SCHADE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 28 2022	BUY Grant, award, or other acquisition	-	32,400 Added 11.11%	259,246 Common Stock
Jun 03 2022	SELL Payment of exercise price or tax liability	$52,616 $0.8 p/Share	65,770 Reduced 22.48%	226,846 Common Stock
May 18 2022	BUY Open market or private purchase	$24,000 $0.64 p/Share	37,500 Added 11.36%	292,616 Common Stock
Mar 10 2022	BUY Grant, award, or other acquisition	-	100,100 Added 28.18%	255,116 Common Stock
Feb 25 2022	SELL Payment of exercise price or tax liability	$37,661 $1.74 p/Share	21,644 Reduced 12.25%	155,016 Common Stock
Feb 25 2021	BUY Grant, award, or other acquisition	-	165,500 Added 48.37%	176,660 Common Stock

Also insider at

IART

INTEGRA LIFESCIENCES HOLDINGS CORP Healthcare

Director

OMGA

Omega Therapeutics, Inc. Healthcare

CSS